Follow this preprint

ROBI: a Robust and Optimized Biomarker Identifier to increase the likelihood of discovering relevant radiomic features

Louis Rebaud, Nicolò Capobianco, Clémentine Sarkozy, Anne-Ségolène Cottereau, Laetitia Vercellino, Olivier Casasnovas, Catherine Thieblemont, Bruce Spottiswoode, Irène Buvat
doi: https://doi.org/10.1101/2024.09.09.24313059
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2024.09.09.24313059
History 
  • September 10, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Louis Rebaud1,2,*,
  2. Nicolò Capobianco3,
  3. Clémentine Sarkozy2,4,
  4. Anne-Ségolène Cottereau2,5,
  5. Laetitia Vercellino6,7,
  6. Olivier Casasnovas8,
  7. Catherine Thieblemont9,10,11,
  8. Bruce Spottiswoode12 and
  9. Irène Buvat2
  1. 1Siemens Healthcare SAS
  2. 2LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France
  3. 3Siemens Healthcare GmbH, Germany
  4. 4Institut Curie, Saint Cloud, Paris, France
  5. 5Department of Nuclear Medicine, Cochin Hospital, AP-HP, Université Paris Cité, Paris, France
  6. 6Department of Nuclear Medicine, Saint-Louis Hospital, AP-HP, Paris, France
  7. 7Inserm, UMR_S942 MASCOT, Université Paris Cité, F-75006, Paris, France
  8. 8Department of Hematology, University Hospital of Dijon, INSERM 1231, Dijon, France
  9. 9Université Paris Cité, 85 boulevard St Germain, F-75006 Paris, France
  10. 10Assistance Publique – Hôpitaux de Paris, Saint Louis Hospital, Hemato-oncology, Paris, France
  11. 11Inserm U1153, Hôpital Saint Louis, 1 avenue Claude Vellefaux, F-75010 Paris, France
  12. 12Siemens Medical Solutions USA, Inc., Knoxville, Tennessee, United States
  1. ↵*Corresponding author:
    Louis Rebaud; email: louis.rebaud{at}gmail.com
Back to top
Posted September 10, 2024.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
ROBI: a Robust and Optimized Biomarker Identifier to increase the likelihood of discovering relevant radiomic features
Louis Rebaud, Nicolò Capobianco, Clémentine Sarkozy, Anne-Ségolène Cottereau, Laetitia Vercellino, Olivier Casasnovas, Catherine Thieblemont, Bruce Spottiswoode, Irène Buvat
medRxiv 2024.09.09.24313059; doi: https://doi.org/10.1101/2024.09.09.24313059
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.